Key facts
- It has raised $50K; the latest was Early Stage VC in Apr 2025.
- Notable investors include Plug and Play Tech Center, Venture Kick, S2S Ventures, Future of Health Grant, SICTIC — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Enhance-d
- ·The full record, as it builds
Funding rounds
No funding rounds for Enhance-d are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enhance-d
Developer of a diabetes self-management platform designed to improve understanding of glucose monitoring and nutritional data for people at risk of diabetes. The company's platform provides a frictionless digital ecosystem to understand the underlying patterns of glucose and monitor clinical outcomes, enabling diabetic patients to manage their diabetes and good health through optimal self-management and improving the quality of their lives.
- Sector
- Healthcare
- HQ
- Bern, Switzerland
- Founded
- 2022
- Employees
- 6
- Website
- enhance-d.com/
- Ownership
- Privately Held (backing)
Enhance-d doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enhance-d shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enhance-d in its N-PORT filings yet. We sweep new filings monthly.